1. What is Retatrutide used for?
Retatrutide is an experimental weight loss and diabetes medication currently under clinical research. It is not approved for medical use anywhere yet.
06 November, 2025 | Holy Winter - Healthcare Writer

Retatrutide is a new experimental medication being researched as a potential weight loss treatment. Developed by Eli Lilly (the same company behind weight management injection Mounjaro), Retatrutide has shown promising early results in clinical trials for reducing body weight - in some cases even more significantly than current medications like Wegovy (semaglutide) or Mounjaro (tirzepatide). However, while these early findings are exciting, Retatrutide is still under investigation. It has not yet been approved for medical use in the UK, EU, or US for weight loss purposes and therefore cannot be recommended as safe and effective at this time.
Retatrutide is part of a new class of weight loss medicine referred to as triple agonists. It targets three key hormone receptors in the body:
This triple action may help users experience stronger effects on satiety (fullness) and energy expenditure compared to current GLP-1 medications.
At this stage, it’s too early to confirm Retatrutide’s long-term safety. While initial clinical trials have reported encouraging average weight loss results, they have also highlighted possible common side effects similar to those seen with GLP-1 agonists, such as:
Currently, Retatrutide is not legal for sale or prescription in the UK. It has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the National Institute for Health and Care Excellence (NICE) for any medical use, including weight loss.
Any websites or sellers claiming to offer Retatrutide for purchase in the UK are likely operating illegally and may be selling unregulated or counterfeit products. Using such products can be dangerous and is strongly discouraged.
If you’re considering weight loss injections, it’s important to choose clinically approved and regulated options.
At iQ Doctor, we offer safe, MHRA-approved treatments including:
Both of these treatments are licensed in the UK for weight management and prescribed safely by registered healthcare professionals.
Retatrutide may represent the next generation of weight loss medications — but as of now, it’s not approved, not legal, and not safe for consumer use in the UK.
If you’re looking for reliable, medically approved treatments, consider Wegovy or Mounjaro, both available from iQ Doctor following an online consultation.
Your health and safety should always come first. Stick to regulated, evidence-backed treatments that are prescribed by trusted UK professionals to assist you on your weight loss journey.
At iQ Doctor, you can access trusted menopause treatments and supplements to help you feel balanced, energised, and in control of your health again.
iQ Doctor is a registered UK pharmacy that specialises in medical remedies for weight loss, erectile dysfunction, hair loss support and much more. Whether you require over-the-counter relief, or prescription-only medication, the experts at iQ Doctor can assist. Please get in touch if you need any further advice.
Also, be sure to keep in touch with iQ Doctor via our social media channels as well as keeping up to date with us by signing up to the mailing list.
Retatrutide is an experimental weight loss and diabetes medication currently under clinical research. It is not approved for medical use anywhere yet.
No, Retatrutide is not legal in the UK. It has not been approved by the MHRA or NICE for any medical purpose.
No. Any Retatrutide sold online in the UK is unregulated and may be counterfeit or unsafe. Always purchase only MHRA-approved treatments.
Wegovy and Mounjaro are there to reduce the risk associated with medically assisted weight loss, and are both approved weight management injections available in the UK through iQ Doctor, with proven effectiveness and medical supervision.
Early trials suggest Retatrutide may be more potent, but it’s still under study. Wegovy and Mounjaro are currently the safest and most effective approved options.

The superintendent and lead pharmacist - registration number 2059792.
Omar is passionate about developing healthcare technology to empower our patients.